双层平板作为创伤愈合和协同作用组合疗法的新平台
Kranthi Gattu1, Andrew Ramirez1, Hua Zhu2
1Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, New York, 11439, USA.
AAPS PharmSciTech
|March 4, 2026
概括
一种新的双层皮肤平板系统为急性伤口管理提供了稳定,便携式的解决方案. 这种创新的配方将膜修复蛋白与抗生素相结合,用于增强愈合和感染控制.
科学领域:
- 生物材料科学 生物材料科学
- 伤口治愈研究研究 伤口治愈研究
- 制药配方 制药配方 制药配方
背景情况:
- 急性伤口管理,特别是烧伤和创伤,带来了重大的临床挑战.
- 传统的局部伤口治疗方法 (膏,奶油,水凝) 往往存在不良的稳定性,便携性和患者的服从性.
- 需要先进的,用户友好的伤口护理解决方案,特别是用于紧急和军事应用.
研究的目的:
- 开发和描述一种新的双层皮肤平板系统,用于有效的急性伤口管理.
- 结合克林达米辛化水,化和复合人体密苏古53 (rhMG53) 的协同组合,以提高治疗效果.
- 为了优化配方以控制药物释放,提高稳定性,便携性和易于应用.
主要方法:
- 通过直接压缩制造了一种双层皮肤平板,其中包括一个保护性的上层和一个治疗性的下层.
- 该配方包括康杰克葡萄甘 (凝剂),油酸 (透性增强剂),克林达米辛化物 (CLC),化 (BKC) 和重新使用的rhMG53.
- 在体外测试中评估了药片特性 (硬度,胀,含量均性),药物释放动力学和配方稳定性.
主要成果:
- 双层平板电脑系统证明了rhMG53的最佳控制释放用于修复和CLC/BKC用于抗菌作用.
- CLC和BKC之间的协同相互作用 (索引1.2) 证实了增强的宽谱抗菌疗效.
- 含有rhMG53的配方在基于细胞的测试中表现出高的药物负载 (98.5%),延长释放和有效的伤口愈合.
结论:
- 开发的双层皮肤平板系统在便携性,稳定性和易于使用方面比传统的伤口护理产品具有显著的优势.
- 该配方的膜修复蛋白和协同抗生素的组合为急性伤口愈合和感染预防提供了一个有希望的策略.
- 这种创新的治疗方法特别适用于资源有限的环境,包括紧急和军事环境.
相关概念视频
01:27Combined Effects of Drugs: Synergism
7.1K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
7.1K
01:27Bioavailability Enhancement: Drug Permeability Enhancement
282
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
282
01:11Oral Drug Delivery Systems: Delayed-Release Systems
80
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...
80
01:28Phases of Wound Repair
9.2K
Following injury, the integrity of the injured tissues must be reestablished. For example, in skin tissue, wound repair involves coordination among resident skin cells, blood mononuclear cells, extracellular matrix, growth factors, and cytokines to complete the healing cascade.
Formation of Blood Clot
In case of deep injuries, trauma to blood vessels results in blood loss. In the meantime, phospholipids released from the ruptured endothelial cellular membrane are converted into arachidonic...
Formation of Blood Clot
In case of deep injuries, trauma to blood vessels results in blood loss. In the meantime, phospholipids released from the ruptured endothelial cellular membrane are converted into arachidonic...
9.2K
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
64
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
64
01:26Oral Drug Delivery Systems: Continuous-Release Systems
104
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
104